Sugi Predict

Sugi Predict / Compounds / SCHEMBL6074466

SCHEMBL6074466

SCHEMBL6074466

CC(=NNC=NN)c1cccc(Nc2nc3c(s2)c(C)c(O)c2ccccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ MEN1 O00255 6/20 0.35
▸ KMT2A Q03164 6/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ GAA P10253 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ POLB P06746 1/20 0.33
▸ RAD52 P43351 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ MAOB P27338 1/20 0.32
▸ VKORC1 Q9BQB6 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CSNK2A2 P19784 1/20 0.32
▸ CSNK2B P67870 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6074390 0.99 PTGS1 (0.39) PTGS1PTGS2ALDH1A1MEN1KMT2A
SCHEMBL6074447 0.85 PLK4 (0.43) PTGS1PTGS2ALDH1A1MEN1KMT2A
SCHEMBL6074435 0.85 PLK4 (0.43) PTGS1PTGS2ALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL6074379 0.84 PLK4 (0.42) PTGS1PTGS2ALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL6074385 0.84 PLK4 (0.42) PTGS1PTGS2ALDH1A1MEN1KMT2A
SCHEMBL6774778 0.80 PTGS1 (0.44) PTGS1PTGS2MEN1KMT2A
Hydrochloric Acid SCHEMBL6074903 0.72 MEN1 (0.50) PTGS1PTGS2ALDH1A1MEN1KMT2A
SCHEMBL6009475 0.71 MEN1 (0.33) ALDH1A1MEN1KMT2ARAB9AGAA
SCHEMBL6774776 0.71 PTGS1 (0.46) PTGS1PTGS2MEN1KMT2A
Hydrochloric Acid SCHEMBL6743159 0.67 KMT2A (0.50) PTGS1PTGS2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689777-B2 DEPOLYMERIZING HEMOZOIN USING 2-IMINO-NAPHTHO(1,2-D)THIAZOL-5-OL DERIVATIVES KENNETH S. WARREN INSTITUTE 2004-02-10 — — US claimed
US-20030186993-A1 Anti-malarial compounds, compositions and methods KENNETH S. WARREN INSTITUTE 2003-10-02 — — US claimed
US-7022721-B1 Method and composition for rejuvenating cells, tissues, organs, hair and nails ULRICH PETER C 2006-04-04 — — US disclosed
US-6689777-B2 DEPOLYMERIZING HEMOZOIN USING 2-IMINO-NAPHTHO(1,2-D)THIAZOL-5-OL DERIVATIVES KENNETH S. WARREN INSTITUTE 2004-02-10 — — US disclosed
US-20030186993-A1 Anti-malarial compounds, compositions and methods KENNETH S. WARREN INSTITUTE 2003-10-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186993-A1 Anti-malarial compounds, compositions and methods TYR, CRYZ, RHOT2 PTGS1 1815/4885PTGS2 1247/4885ALDH1A1 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.